New Risperdal lawsuit claims are still being filed in 2026, and the window to act is narrowing fast. If you or your child took Risperdal and experienced serious side effects, your legal rights may still be intact, but only if you move before state deadlines cut them off permanently.
This drug has been at the center of one of the largest pharmaceutical legal battles in American history. Johnson and Johnson paid over $2.2 billion in a federal settlement in 2013 alone, and individual lawsuits have produced verdicts in the tens of millions.
This article breaks down everything you need to know right now. Who still qualifies. What the 2026 deadlines mean. How much settlements typically pay. And exactly what you need to do to file.
Risperdal Lawsuit 2026: What Is Happening Right Now
The Risperdal lawsuit in 2026 refers to ongoing personal injury claims against Johnson and Johnson and its subsidiary Janssen Pharmaceuticals over harm caused by the antipsychotic drug risperidone, sold under the brand name Risperdal.
The bulk of the mass tort litigation concluded over the past decade. But individual claims are still being filed and litigated in 2026, particularly in states where the statute of limitations clock has not yet expired for all affected individuals.
This is not a closed case. Courts in Pennsylvania and other jurisdictions continue to see Risperdal-related filings. Late-diagnosed injuries and newly turned adult plaintiffs are among those still entering the legal process this year.
| Key 2026 Status Detail | Current Information |
|---|---|
| Active Claims | Yes, individual filings ongoing |
| Primary Courts | Philadelphia Court of Common Pleas; federal courts |
| Main Defendants | Johnson and Johnson, Janssen Pharmaceuticals |
| Primary Injuries Claimed | Gynecomastia, diabetes, tardive dyskinesia |
| Federal DOJ Settlement | $2.2 billion (resolved 2013) |
The legal fight in 2026 is not about re-litigating the DOJ settlement. It is about individual plaintiffs seeking compensation for personal harm caused by a drug that regulators, juries, and courts have repeatedly found was marketed irresponsibly.
Risperdal Lawsuit Deadline: When Do You Have to File?
The Risperdal lawsuit deadline in 2026 depends entirely on the state where you or your child took the drug and where the injury occurred.
There is no single national deadline. Each state has its own statute of limitations for pharmaceutical personal injury claims. Most run between two and four years from the date of injury discovery.
The critical phrase here is “discovery.” Many courts apply what is called the “discovery rule,” which means the clock starts not when you took the drug, but when you first knew, or reasonably should have known, that the drug caused your injury. This distinction has allowed claims to survive well past the initial prescription period.
| State | General Personal Injury SOL | Notes for Risperdal Claims |
|---|---|---|
| Pennsylvania | 2 years | Discovery rule applies |
| California | 2 years | Discovery rule may extend window |
| New York | 3 years | Date of discovery triggers clock |
| Texas | 2 years | Strict interpretation in some courts |
| Florida | 2 years (reduced from 4 in 2023) | Recent legislative change applies |
If you are unsure whether your deadline has passed, you need a legal review immediately. Missing the statute of limitations means losing your right to any compensation, permanently.
Risperdal Lawsuit Who Qualifies: Are You Eligible to File?
You may qualify for a Risperdal lawsuit if you or a family member took the drug and suffered a documented side effect that was not adequately disclosed.
The core eligibility requirements center on three factors: exposure to Risperdal, a qualifying injury, and a filing deadline that has not yet expired.
Children prescribed Risperdal for conditions like ADHD, autism, or behavioral disorders, when the drug was not FDA-approved for those uses, form the largest group of claimants. But adults who suffered harm are also eligible to file.
Basic eligibility checklist:
- Took Risperdal (risperidone) at any point, particularly before 2007
- Developed gynecomastia, diabetes, tardive dyskinesia, or hyperprolactinemia
- Have medical records linking the drug to the diagnosis
- Have not previously settled or received compensation for the same claim
- Are within your state’s statute of limitations window
Children who were prescribed Risperdal off-label and are now adults may have their own independent right to file, separate from any claim their parents previously pursued. This is a key point that many families miss.
Key Takeaway: The Risperdal lawsuit is still active in 2026, deadlines vary by state, and both children (now adults) and adults who took the drug may qualify to file claims.
Risperdal Lawsuit Settlement Amount: What Have Past Cases Paid?
Risperdal lawsuit settlement amounts have ranged from thousands of dollars to tens of millions, depending on the severity of the injury and the strength of the individual case.
There is no single fixed settlement fund in 2026 for new claimants. The mass resolution of thousands of cases happened through private negotiations and multi-district litigation. Individual cases now proceed on their own merits.
Past verdicts offer a useful benchmark. In 2015, a jury awarded $2.5 million to a young man who developed gynecomastia after taking Risperdal. In 2019, a verdict reached $8 billion in punitive damages before being reduced on appeal. These numbers signal how seriously courts have viewed the misconduct involved.
| Claim Type | Historical Payout Range | Factors Affecting Amount |
|---|---|---|
| Gynecomastia (minor) | $50,000 to $250,000 | Degree of breast tissue growth |
| Gynecomastia (surgery required) | $200,000 to $1.5 million | Medical costs, emotional harm |
| Diabetes diagnosis | $100,000 to $500,000+ | Age, prior health, duration |
| Tardive dyskinesia | $250,000 to $1 million+ | Permanence of condition |
| Punitive damage verdicts | Up to $8 billion (reduced) | Degree of corporate misconduct |
Individual 2026 settlements are negotiated privately. No public database exists for current amounts. But cases with strong medical documentation and clear causal links to Risperdal have consistently produced meaningful compensation.
How Much Is a Risperdal Lawsuit Worth in 2026?
A Risperdal lawsuit in 2026 is potentially worth anywhere from tens of thousands to several hundred thousand dollars for most qualifying claimants.
The total value depends on several interacting factors. Severity of the physical injury matters most. Medical treatment costs, including surgical correction of gynecomastia, factor into the calculation. Emotional distress and loss of quality of life add to the figure.
Think of it like a car insurance claim. A minor fender bender pays far less than a total loss. The more severe and documented your injury, the stronger your case value.
Factors that increase claim value:
- Gynecomastia requiring surgery
- Diagnosis of Type 2 diabetes linked to Risperdal use
- Long duration of Risperdal use before side effects were disclosed
- Young age at time of prescription
- Off-label prescription with no approved indication
- Emotional or psychological harm documented by a mental health professional
Cases with multiple qualifying injuries or long exposure periods have historically attracted higher settlement offers and larger jury awards.
Risperdal Lawsuit Gynecomastia: The Core of Most Claims
Gynecomastia is the abnormal development of breast tissue in males, and it is the injury at the center of the vast majority of Risperdal lawsuits.
Risperdal causes elevated levels of prolactin, a hormone that stimulates breast tissue growth. In young boys, this can result in significant and permanent breast enlargement. The condition is not just physical. It causes serious psychological harm, particularly during adolescence.
Thousands of boys developed gynecomastia while taking Risperdal for off-label conditions. Many required surgery to correct it. Some lived with the condition for years before connecting it to the drug.
What makes a gynecomastia claim strong:
- Medical records showing Risperdal prescription during development years
- Diagnosis of gynecomastia by a physician
- Evidence of elevated prolactin levels in lab work
- Documentation of surgical treatment or recommendation for surgery
- Psychological records showing emotional impact
The 2015 trial verdict of $2.5 million for a single gynecomastia plaintiff set an important precedent. Courts have repeatedly found that Johnson and Johnson failed to adequately warn patients and prescribers about this risk.
Risperdal Lawsuit Johnson and Johnson: Who Is Being Sued?
Johnson and Johnson, through its pharmaceutical subsidiary Janssen Pharmaceuticals, is the primary defendant in Risperdal lawsuits.
Janssen developed and marketed Risperdal. The FDA first approved it in 1993 for schizophrenia in adults. The problem came when Johnson and Johnson aggressively promoted it for uses the FDA had never approved, including treatment of behavioral issues in children with autism and ADHD.
In 2013, the U.S. Department of Justice announced that Johnson and Johnson agreed to pay $2.2 billion to resolve federal criminal and civil allegations over this off-label marketing. That settlement covered marketing fraud, not individual injury claims.
Individual plaintiffs have continued suing separately for personal harm. Johnson and Johnson has spent years in Philadelphia courts fighting and settling these individual cases.
| DOJ Settlement 2013 | Details |
|---|---|
| Total Settlement | $2.2 billion |
| Criminal Plea | Janssen pleaded guilty to misbranding |
| Scope | Off-label marketing to children, elderly |
| Individual Claims | Resolved separately through litigation |
The corporate misconduct documented in that DOJ case strengthens individual Risperdal lawsuits significantly, because it establishes that the company knew about risks and promoted the drug anyway.
Key Takeaway: Johnson and Johnson and its subsidiary Janssen Pharmaceuticals are the defendants, and their 2013 federal guilty plea to drug misbranding gives individual claimants powerful supporting evidence.
Risperdal Lawsuit Side Effects Eligible: Which Injuries Qualify?
Not every side effect from Risperdal qualifies for a lawsuit. The claims courts have recognized fall into specific medical categories.
Gynecomastia is the most common qualifying injury. But several other serious conditions have also formed the basis of successful claims.
Recognized qualifying side effects for Risperdal lawsuits:
- Gynecomastia: Abnormal breast tissue growth in males due to hyperprolactinemia
- Type 2 diabetes: Drug-induced insulin resistance linked to antipsychotic use
- Tardive dyskinesia: Involuntary muscle movements, often permanent
- Hyperprolactinemia: Abnormally high prolactin levels causing multiple complications
- Stroke: Elevated risk documented in elderly patients
- Weight gain complications: Leading to secondary metabolic conditions
Side effects like general discomfort, temporary nausea, or mild mood changes do not typically form the basis of a viable lawsuit. The injury must be serious, documented, and causally linked to Risperdal use.
Medical records that show both the Risperdal prescription and the qualifying diagnosis are the foundation of any successful claim.
Risperdal Lawsuit for Adults: Can Grown-Up Patients Still File?
Adults who took Risperdal and suffered harm can absolutely still file a lawsuit in 2026, and this group is frequently overlooked in coverage of this litigation.
Risperdal was approved for adult use in schizophrenia and bipolar disorder. Adults who were prescribed it on-label and still suffered serious side effects, particularly diabetes or tardive dyskinesia, have valid legal claims.
There is a separate and important category here. Children who were prescribed Risperdal years ago are now adults. When they turn 18, they often gain an independent right to file their own personal injury claim, separate from anything their parents did or did not do during their childhood.
| Adult Claimant Type | Claim Basis | Key Deadline Consideration |
|---|---|---|
| Adults prescribed on-label | Personal injury from undisclosed risks | SOL from date of diagnosis/discovery |
| Former child patients now adults | Independent right to file upon turning 18 | Many states restart the SOL clock at age 18 |
| Elderly patients | Stroke risk, diabetes | SOL from date of injury discovery |
If you took Risperdal as a child and are now between 18 and 22, your window may still be open. This is a time-sensitive situation worth investigating before that independent right expires.
Risperdal Lawsuit Diabetes Claims: A Growing Category of Cases
Drug-induced Type 2 diabetes is a serious and increasingly recognized category of Risperdal litigation.
Antipsychotic medications, including Risperdal, have been linked to metabolic changes that can trigger insulin resistance and diabetes. For some patients, a diabetes diagnosis linked to Risperdal use forms a standalone legal claim even if they did not develop gynecomastia.
The FDA required Janssen to add a warning about hyperglycemia and diabetes risk to the Risperdal label in 2003. Patients who developed diabetes before that warning, or whose prescribers were not adequately informed of the risk, may have the strongest claims.
Diabetes claim eligibility factors:
- Risperdal use prior to or after the 2003 FDA warning update
- Diagnosis of Type 2 diabetes with no prior risk factors or family history
- Evidence that prescriber was not adequately warned about metabolic risks
- Medical records documenting the sequence: prescription, then diagnosis
- Duration of Risperdal use before diabetes onset
Diabetes claims tend to involve higher medical costs and longer-term harm than some other claims, which can translate into larger settlement values for qualifying plaintiffs.
Key Takeaway: Adults, former child patients now over 18, and those who developed diabetes as a direct result of Risperdal use all have distinct and valid legal pathways in 2026.
Risperdal Lawsuit Filing Deadline 2026: What Dates Matter This Year
The most critical filing deadlines in the Risperdal lawsuit context for 2026 are the state-specific statute of limitations dates that will permanently bar late filers.
For former child patients who turned 18 in 2024, some states’ two-year clocks expire in 2026. This makes the current year a high-stakes window for a specific subset of plaintiffs.
There is no court-imposed federal deadline for new individual claims in 2026 at this time. The deadlines that matter are statutory. They are set by state law, not by a judge or a settlement administrator.
| Claimant Type | When SOL Clock Typically Starts | 2026 Relevance |
|---|---|---|
| Adult who took Risperdal | Date injury was discovered | High if injury diagnosed recently |
| Child now turning 18 in 2024 | 18th birthday in most states | 2-year window may close in 2026 |
| Child now turning 18 in 2025 | 18th birthday | Window open through 2026-2027 |
| Adult diagnosed with diabetes | Date of diabetes diagnosis | Depends on when diagnosed |
The practical takeaway: if you turned 18 in 2024 and were prescribed Risperdal as a minor, 2026 may be your last realistic year to file in many states. Do not wait until December to start that process.
Risperdal Lawsuit Statute of Limitations: How Long Do You Have?
The statute of limitations for a Risperdal lawsuit is the legal deadline by which a claim must be filed, and it varies by state, by claimant type, and by the nature of the injury.
Most states set personal injury statutes of limitations between two and four years. But two doctrines extend these windows in Risperdal cases specifically.
First is the discovery rule, which starts the clock from the date you knew or should have known the drug caused your injury, not the date of the prescription. Second is minority tolling, which means the clock does not start running for a child plaintiff until they turn 18.
Key tolling and extension doctrines:
- Discovery rule: Clock starts at date of injury discovery, not drug use
- Minority tolling: Minors do not face the SOL until they turn 18
- Fraudulent concealment: If Johnson and Johnson concealed risks, courts may toll the period
- Continuous treatment doctrine: Applies in some states if treatment was ongoing
These doctrines can make the difference between a viable claim and a dismissed one. Whether they apply to your situation depends on the state and the specific facts of your case.
Risperdal Lawsuit How to File: Steps to Start Your Claim in 2026
Filing a Risperdal lawsuit in 2026 follows a structured process that begins with gathering your medical records and identifying an experienced pharmaceutical litigation attorney.
You do not file directly with a court on day one. The process starts with an intake and evaluation phase, where you share your medical history and an attorney determines whether your claim meets the legal threshold.
Here is the step-by-step process most Risperdal claimants follow:
Step 1: Gather your medical records
Collect all records showing Risperdal prescriptions, dosage history, and any diagnoses of qualifying injuries.
Step 2: Document the injury
Get current medical documentation of gynecomastia, diabetes, tardive dyskinesia, or other qualifying conditions.
Step 3: Contact a mass tort attorney
Find an attorney who handles pharmaceutical litigation specifically. General personal injury firms may not have the resources to pursue these cases effectively.
Step 4: Case evaluation
The attorney reviews your records and determines eligibility. This process is typically free.
Step 5: File the complaint
Your attorney prepares and files the legal complaint in the appropriate court.
Step 6: Discovery and negotiation
Medical experts, depositions, and negotiations with Johnson and Johnson’s defense teams follow.
Step 7: Settlement or trial
Most cases settle. A small percentage proceed to trial.
Risperdal Lawsuit Evidence Needed: What Documents Strengthen Your Case
Strong evidence is the difference between a settled Risperdal claim and a dismissed one. The more documentation you have, the stronger your position.
The foundation of every Risperdal case is a clear paper trail connecting the drug to the injury. Courts and defense attorneys will look for any gap in that chain.
Essential evidence for a Risperdal lawsuit:
- Prescription records: Pharmacy records or doctor notes showing Risperdal was prescribed
- Medical records: Diagnosis records for gynecomastia, diabetes, or other qualifying conditions
- Lab results: Prolactin levels, blood glucose tests, hormone panels
- Surgical records: If gynecomastia surgery was performed, all related records
- Psychological records: Documentation of emotional distress, particularly for young male plaintiffs
- School records: For children, records showing behavioral or developmental changes during drug use
- Expert testimony: Medical experts who can testify to the causal connection between Risperdal and the injury
One thing that surprises many claimants: pharmacy records from major chains like CVS, Walgreens, and Rite Aid often go back seven to ten years. Even if you no longer have your prescription paperwork, pharmacies may have the fill history on record.
Key Takeaway: Prescription records, medical diagnosis documentation, and lab results are the three pillars of a strong Risperdal lawsuit. Missing any of these weakens the case significantly.
Risperdal Mass Tort vs Individual Lawsuit: Which Path Is Right for You
A Risperdal mass tort and an individual lawsuit are two different legal structures, and which one applies to your case in 2026 depends on several factors.
A mass tort groups many individual plaintiffs with similar injuries and similar claims against the same defendant. Each plaintiff still has their own case. Compensation is individual, not shared like a class action. The MDL (multi-district litigation) structure previously used for Risperdal cases in Pennsylvania was a mass tort.
An individual lawsuit is a standalone case filed in state or federal court. In 2026, most new Risperdal claims proceed as individual lawsuits rather than joining an existing MDL, since the primary MDL is no longer actively accepting new cases in the way it once was.
| Feature | Mass Tort / MDL | Individual Lawsuit |
|---|---|---|
| Number of plaintiffs | Thousands | One (or a family) |
| Settlement | Individual amounts | Individual amounts |
| Court | Federal MDL court | State or federal |
| Timeline | Can be faster in active MDL | Variable |
| Evidence sharing | Shared expert resources | Case-specific |
| 2026 availability | Limited new MDL intake | Primary path for new filers |
For 2026 filers, an individual lawsuit in state court is the most practical avenue. An attorney can evaluate whether any consolidated proceedings exist that might be advantageous for your specific claim.
Risperdal Lawsuit Update 2026: Where Things Stand Right Now
The Risperdal lawsuit landscape in 2026 is in a late-stage phase where new individual claims remain viable, but the era of mass MDL processing has largely passed.
Johnson and Johnson has spent over a decade resolving Risperdal claims. The 2013 DOJ settlement addressed marketing fraud. Thousands of personal injury cases were resolved through the Philadelphia Court of Common Pleas and the federal MDL system. But new cases keep arriving.
Several categories of claimants are responsible for the continued 2026 activity:
- Former child patients who have only recently turned 18 and can now file independently
- Adults who received a diabetes diagnosis in recent years and connected it to past Risperdal use
- Individuals who only recently discovered their gynecomastia was drug-induced, triggering the discovery rule
- Families in states where tolling provisions created a longer window
2026 litigation snapshot:
| Category | Status |
|---|---|
| Federal MDL | Largely resolved; limited new intake |
| Philadelphia state court | Still active for individual filings |
| Individual state court filings | Ongoing nationwide |
| Johnson and Johnson defense posture | Active litigation; case-by-case settlement |
| New plaintiff categories | Former child patients now adults; late-diagnosed diabetes |
The window is narrowing. Each year that passes, fewer claimants remain within a valid statute of limitations period. 2026 is a significant year for anyone who has been on the fence about filing.
Frequently Asked Questions
Can I still file a Risperdal lawsuit in 2026?
Yes, new Risperdal lawsuits are still being filed in 2026.
The viability of your specific claim depends on your state’s statute of limitations and when your injury was discovered or diagnosed.
Former child patients who recently turned 18 and adults with newly diagnosed conditions are among those still within valid filing windows.
How much money can I get from a Risperdal lawsuit settlement?
Settlement amounts in Risperdal cases have ranged from tens of thousands to several million dollars depending on injury severity.
Gynecomastia cases requiring surgery have historically settled in the range of $200,000 to over $1 million.
Diabetes and tardive dyskinesia claims can reach similar or higher values depending on the permanence and severity of the condition.
What side effects qualify for a Risperdal lawsuit claim?
The primary qualifying side effects are gynecomastia, Type 2 diabetes, tardive dyskinesia, and hyperprolactinemia.
Stroke risk in elderly patients and serious metabolic complications have also formed the basis of valid claims.
General side effects like nausea or weight gain without a serious secondary diagnosis typically do not meet the legal threshold for a lawsuit.
What is the filing deadline for the Risperdal lawsuit in 2026?
There is no single national deadline. Each state sets its own statute of limitations, typically two to four years from the date of injury discovery.
For former child patients who turned 18 in 2024, some state deadlines fall within 2026, making this year critical.
The discovery rule may extend your window if you only recently connected your diagnosis to Risperdal use.
What evidence do I need to file a Risperdal lawsuit?
You need prescription records showing Risperdal use, medical records documenting your qualifying injury, and any lab results supporting the diagnosis.
Surgical records for gynecomastia corrections, psychological evaluations, and pharmacy fill histories all strengthen the case.
Even if you no longer have paperwork, pharmacy chains often retain prescription history for seven to ten years, so records may still be recoverable.
What to Do Before the 2026 Window Closes
The time to act on a Risperdal lawsuit is before your state’s deadline cuts off your right to compensation.
Start by pulling together your medical records and any prescription history. Even partial records give an attorney enough to evaluate your case. The evaluation itself costs you nothing with most pharmaceutical litigation firms.
If you or a family member took Risperdal, developed gynecomastia, diabetes, or another serious condition, and have not yet spoken to an attorney, 2026 may be the year you run out of time. Filing now is the only way to know whether you have a claim worth pursuing
